Nada Elbuluk, MD

Title(s)Clinical Associate Professor of Dermatology (Clinician Educator)
Address1450 San Pablo St.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Princeton University, Princeton, NJBA
    University of Michigan, Ann Arbor, MIMScClinical Research
    University of Michigan, Ann Arbor, MIMDMedicine
    Johns Hopkins, Baltimore, MDDermatology, Residency
    University of Pennsylvania, Philadelphia, PADermatology, Fellowship

    Collapse Overview 
    Collapse Overview
    Dr. Nada Elbuluk is a board-certified dermatologist and Assistant Professor at the USC Keck School of Medicine, Department of Dermatology. She is honored to be a dermatologist at USC and to be able to serve the diverse population of Los Angeles. She is the founder and director of the USC Skin of Color Center and Pigmentary Disorders Clinic. She also serves as the Director of the Dermatology Diversity and Inclusion Program.

    Dr. Elbuluk’s clinical and research interests include general medical and cosmetic dermatology,
    ethnic skin conditions, and pigmentary disorders including vitiligo, melasma, and postinflammatory pigmentation. She performs a variety of procedures including chemical peels, microneedling, lasers, and botox and has expertise in safely performing these procedures in all skin types.

    Dr. Elbuluk received her bachelor’s degree in Psychology from Princeton University where she also minored in Gender Studies and African American Studies. She completed her medical degree at the University of Michigan where she graduated with a Distinction in Research. While there, she received a National Institute of Health award that allowed her to also obtain a Master of Science in Clinical Research from the University of Michigan School of Public Health. She completed her dermatology residency at Johns Hopkins Hospital. Afterwards, she was a fellow and clinical instructor in the Dermatology Department at The University of Pennsylvania. She then spent four years as an Assistant Professor at New York University’s School of Medicine, where she was the founder and director of the pigmentary disorder clinic and served as the Diversity Ambassador for the Department.

    Dr. Elbuluk feels strongly about providing her patients with the highest quality of individualized and compassionate care. She also is passionate about teaching and advancing the field of dermatology through research on pigmentary disorders and ethnic skin conditions. She has received several grants to support her research, which has been published in numerous academic journals. She has lectured both national and internationally on her areas of expertise. She also serves as a media expert for the American Academy of Dermatology and has been interviewed by numerous media outlets including the Washington Post, Health, Women’s Health, Essence, Prevention, Allure, Reader’s Digest, the Huffington Post, SELF, and NBC.com.

    Dr. Elbuluk is a Diplomate of the American Academy of Dermatology and holds professional memberships with the American Academy of Dermatology, the Women’s Dermatologic Society, the American Society for Dermatologic Surgery, and the Skin of Color Society.

    Collapse ORNG Applications 
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vitiligo and Melanoma-Associated Vitiligo: Understanding Their Similarities and Differences. Am J Clin Dermatol. 2020 Oct; 21(5):669-680. Cohen BE, Manga P, Lin K, Elbuluk N. PMID: 32468356.
      View in: PubMed   Mentions:    Fields:    
    2. A quantitative analysis of research publications focused on the top chief complaints in skin of color patients. J Am Acad Dermatol. 2020 Aug 12. Montgomery SN, Elbuluk N. PMID: 32800869.
      View in: PubMed   Mentions:    Fields:    
    3. Postinflammatory hypopigmentation: a comprehensive review of treatments. J Dermatolog Treat. 2020 Jul 20; 1-5. Madu PN, Syder N, Elbuluk N. PMID: 32643458.
      View in: PubMed   Mentions:    Fields:    
    4. The digital divide: How COVID-19's telemedicine expansion could exacerbate disparities. J Am Acad Dermatol. 2020 11; 83(5):e345-e346. Bakhtiar M, Elbuluk N, Lipoff JB. PMID: 32682890.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    5. The Relevance of Vitamin D Supplementation for People of Color in the Era of COVID-19. J Drugs Dermatol. 2020 Jul 01; 19(7):782-783. Grimes PE, Elbuluk N, Alexis AF. PMID: 33528149.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Evaluating Population Interest in Vitiligo Through an Analysis of Google Trends and Social Media. J Drugs Dermatol. 2020 Jun 01; 19(6):661-665. Montgomery SNB, Elbuluk N. PMID: 32574016.
      View in: PubMed   Mentions:    Fields:    
    7. Why can we see our narrowband UVB lights? J Am Acad Dermatol. 2020 06; 82(6):e251-e252. Soleymani T, Soter NA, Folan LM, Elbuluk N, Cohen DE. PMID: 32109539.
      View in: PubMed   Mentions:    Fields:    
    8. Photolichenoid dermatitis: a presenting sign of human immunodeficiency virus. Cutis. 2019 Oct; 104(4):242-244. Curtiss P, Riley K, Meehan SA, Elbuluk N. PMID: 31809532.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Comorbid diseases of vitiligo: A 10-year cross-sectional retrospective study of an urban US population. J Am Acad Dermatol. 2020 Mar; 82(3):628-633. Hadi A, Wang JF, Uppal P, Penn LA, Elbuluk N. PMID: 31325552.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Frontal fibrosing alopecia: cutaneous associations in women with skin of color. Cutis. 2018 Nov; 102(5):335-338. Krueger L, Svigos K, Brinster N, Elbuluk N. PMID: 30566548.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Deficiency of sun protection advertising exists in consumer magazines across demographic groups and varies by target demographic. J Am Acad Dermatol. 2019 Apr; 80(4):1139-1141. Wiznia LE, Wang J, Steuer AB, Elbuluk N. PMID: 30315819.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation. Br J Dermatol. 2019 03; 180(3):574-579. Eleftheriadou V, Hamzavi I, Pandya AG, Grimes P, Harris JE, Huggins RH, Lim HW, Elbuluk N, Bhatia B, Tovar-Garza A, Nahhas AF, Braunberger T, Ezzedine K. PMID: 30030843.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo. J Drugs Dermatol. 2018 Jun 01; 17(6):688-691. Rzepecki AK, McLellan BN, Elbuluk N. PMID: 29879259.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Disparity in Cutaneous Pigmentary Response to LED vs Halogen Incandescent Visible Light: Results from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose. J Drugs Dermatol. 2017 Nov 01; 16(11):1105-1110. Soleymani T, Cohen DE, Folan LM, Okereke UR, Elbuluk N, Soter NA. PMID: 29141058.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    15. Melasma: an Up-to-Date Comprehensive Review. Dermatol Ther (Heidelb). 2017 Sep; 7(3):305-318. Ogbechie-Godec OA, Elbuluk N. PMID: 28726212.
      View in: PubMed   Mentions:
    16. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone. Exp Dermatol. 2017 07; 26(7):637-644. Arowojolu OA, Orlow SJ, Elbuluk N, Manga P. PMID: 28370349.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    17. A Difference in Cutaneous Pigmentary Response to LED Versus Halogen Incandescent Visible Light: A Case Report from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose. J Drugs Dermatol. 2017 Apr 01; 16(4):388-392. Soleymani T, Soter NA, Folan LM, Elbuluk N, Okereke UR, Cohen DE. PMID: 28403275.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    18. Daily indoor light exposure: A spectral analysis of ambient light sources and its relevance to occupational dermatology. J Am Acad Dermatol. 2017 04; 76(4):763-765. Soleymani T, Folan LM, Soter NA, Elbuluk N, Cohen DE. PMID: 28325397.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    19. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients. Dermatol Clin. 2017 Apr; 35(2):117-128. Elbuluk N, Ezzedine K. PMID: 28317521.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Microneedling: A Comprehensive Review. Dermatol Surg. 2017 Mar; 43(3):321-339. Hou A, Cohen B, Haimovic A, Elbuluk N. PMID: 27755171.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    21. Advances in Vitiligo: An Update on Medical and Surgical Treatments. J Clin Aesthet Dermatol. 2017 Jan; 10(1):15-28. Dillon AB, Sideris A, Hadi A, Elbuluk N. PMID: 28210378.
      View in: PubMed   Mentions:
    22. Lichen planus pigmentosus and lichen planopilaris. Dermatol Online J. 2016 Dec 15; 22(12). Cobos G, Kim RH, Meehan S, Elbuluk N. PMID: 28329547.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Lichen planus pigmentosus. Dermatol Online J. 2016 Dec 15; 22(12). Orme CM, Kim RH, Brinster N, Elbuluk N, Franks AG. PMID: 28329536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Common conditions in skin of color. Semin Cutan Med Surg. 2016 Dec; 35(4):184-190. Hadi A, Elbuluk N. PMID: 27917999.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Recent advances in understanding vitiligo. F1000Res. 2016; 5. Manga P, Elbuluk N, Orlow SJ. PMID: 27635239.
      View in: PubMed   Mentions: 11     Fields:    
    26. Infrared irradiation differentially alters collagen metabolism in lightly and darkly pigmented human skin in vivo. J Dermatol Sci. 2016 Jun; 82(3):212-4. Elbuluk N, Wang F, Tran BA, Hammerberg C, Voorhees JJ, Kang S, Fisher GJ. PMID: 27020409.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    27. Microneedling in skin of color: A review of uses and efficacy. J Am Acad Dermatol. 2016 Feb; 74(2):348-55. Cohen BE, Elbuluk N. PMID: 26549251.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Cutaneous Rosai-Dorfman Disease in a Patient with Human Immunodeficiency Virus. Dermatol Online J. 2016 Jan 15; 22(1). Elbuluk N, Egbers R, Taube JM, Wang TS. PMID: 26990470.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    29. Alternative Systemic Treatments for Vitiligo: A Review. Am J Clin Dermatol. 2015 Dec; 16(6):463-74. Cohen BE, Elbuluk N, Mu EW, Orlow SJ. PMID: 26329814.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    30. Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses. Am J Pathol. 2011 Apr; 178(4):1434-41. Nesterovitch AB, Gyorfy Z, Hoffman MD, Moore EC, Elbuluk N, Tryniszewska B, Rauch TA, Simon M, Kang S, Fisher GJ, Mikecz K, Tharp MD, Glant TT. PMID: 21406173.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    31. What is your diagnosis? Multiple cutaneous and uterine leiomyomatosis (Reed Syndrome). Cutis. 2011 Feb; 87(2):65, 76-7. Elbuluk N, Bichakjian CK, Lowe L. PMID: 21416770.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Erythema nodosum leprosum, Sweet's syndrome, and human immunodeficiency virus may be related through an overlap in immunopathogenesis. Int J Dermatol. 2010 Nov; 49(11):1344-5. Elbuluk N, Martiniuk F, Levis WR. PMID: 20964666.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne. J Am Acad Dermatol. 2009 Aug; 61(2):252-8. Wang F, Kwak HS, Elbuluk N, Kaczmarek AL, Hamilton T, Voorhees JJ, Fisher GJ, Kang S. PMID: 19525031.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    Nada's Networks
    Concepts (173)
    Derived automatically from this person's publications.
    Co-Authors (1)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department